Skip to main content
. 2021 Mar 31;129(3):037010. doi: 10.1289/EHP8222

Figure 3.

Figure 3A1 and 3A2 titled acute are line graphs plotting Glucose (milligram per deciliter), ranging from 120 to 180 in increments of 20 and Pyruvate (nanogram per milliliter), ranging from 0 to 500 in increments of 100 (y-axis) across epidermal growth factor (microgram per gram), ranging from 0.0001 to 0.001 in increments of 0.0009, 0.001 to 0.01 in increments of 0.009, 0.01 to 0.1 in increments of 0.09, and 0.1 to 1 in increments of 0.9 (x-axis), respectively. Figure 3B1 and 3B2 titled chronic are box plot graphs, ranging from Glucose (milligram per deciliter), ranging from 0 to 600 in increments of 200 and Pyruvate (nanogram per milliliter), ranging from 0 to 2000 in increments of 500 (y-axis) across control plus saline, control plus epidermal growth factor, aroclor 1260 plus saline, and aroclor 1260 plus epidermal growth factor (x-axis), respectively. Figures 3C1 and 3D1 are line graphs plotting Glucose (milligram per deciliter), ranging from 100 to 400 in increments of 100 and 50 to 250 in increments of 50 (y-axis) across Time (minutes), ranging from 0 to 150 in increments of 50 and 0 to 100 in increments of 50 (x-axis) for control plus saline, control plus epidermal growth factor, aroclor 1260 plus saline, and aroclor 1260 plus epidermal growth factor, respectively. Figures 3C2 and 3D2 are box plots graphs plotting Glucose tolerance test area under the curve, ranging from 10000 to 50000 in increments of 10000 and Insulin tolerance test area under the curve, ranging from 0 to 30000 in increments of 10000 (y-axis) across control plus saline, control plus epidermal growth factor, aroclor 1260 plus saline, and aroclor 1260 plus epidermal growth factor (x-axis), respectively.

Effects on hepatic gluconeogenesis, insulin sensitivity, and glucose tolerance in mice treated acutely with EGF alone or chronically in HFD-fed mice exposed to Aroclor 1260±EGF treatment. Male WT C57Bl/6 mice fed a control diet were treated with either saline or EGF at multiple doses (0.002, 0.02, 0.2μg/g), followed by euthanasia at 30 min post IP injection, and tissue was harvested for downstream analysis. Male WT C57Bl/6 mice were fed an HFD (12 wk) and exposed to either vehicle or Aroclor 1260 (20mg/kg) by a one-time oral gavage at week 1. Aroclor 1260-exposed or vehicle mice were treated (via IP injection) with saline or EGF (0.2mg/g) daily for 10 d starting at week 10. Mice were fasted for 12 h and euthanized, and tissues were harvested for downstream analyses. (A) Plasma glucose (Ai) and plasma pyruvate (Aii) were measured in mice treated with EGF (0.002, 0.02, 0.2μg/g) or saline control for 30 min (acute). (B) Plasma glucose (Bi) and plasma pyruvate (Bii) were measured in mice gavaged with corn oil and injected with either saline (CS) or EGF (0.2μg/g) (CE) or gavaged with Aroclor 1260 (20mg/kg) and injected with saline (AS) or EGF (AE) at the conclusion of the chronic model (12 wk). (Ci-ii) GTTs were performed in the CS, CE, AS, and AE mice as well as (Di-ii) ITTs. An n=5 was used for Figures 3Ai–ii, and the red dot is the mean±SEM for saline controls for Figures 3Ai–ii. An n=17 was used for Figures 3B–D. A two-way ANOVA was used to statistically compare data sets, followed by a Sidak correction for intergroup comparisons. A p<0.05 was considered significant. Significance due to EGF is denoted by (a); Aroclor 1260 denoted by (b); and due to interaction denoted by (c) for the two-way ANOVA. A p<0.05 was denoted by * for the Sidak multiple comparison test. Data are represented as mean±SEM for Figures 3Ai, 3Aii, 3Ci, and 3Di, but data are presented as box and whisker plots for Figures 3Bii, 3Cii, and 3Dii that illustrate the median (midline), upper and lower quartiles (box), and the upper and lower limits (whiskers). All numerical data are presented in Table S6 “Numerical Data” as mean±SD, and p-values can be found in Table S5. Numeric outliers were identified by ROUT method and removed. The number of outliers are reported in Table S4. Note: AE, Aroclor 1260+EGF; ANOVA, analysis of variance; AS, Aroclor 1260+saline; CE, control+EGF; CS, control+saline; EGF, epidermal growth factor; GTT, glucose tolerance test; HFD, high-fat diet; IP, intraperitoneal; ITT, insulin tolerance test.